| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |